VUmc Stichting

Amsterdam 31 trials 9 recruiting

31 Registered trials

9 Currently recruiting

Organisation

VUmc Stichting

Location

Amsterdam, Netherlands

Identifier

ORG-100021154

Address

De Boelelaan 1117, 1081 HV, Netherlands

Departments

#8003: Pulmonology
Anesthesiolog
Cardiology
Clinical Endocrinology and Internal medicine
Department of Hematology
Department of Pulmonary Medicine
Department of Pulmonology
Endocrinology
Gastroenterology and hepatology
Hematology
k.sigaloff
Longziekten
Medical Oncology
Neurologie
Neurology
Pulmonary department
Pulmonary Disease
Pulmonary diseases
Pulmonary Medicine
Rheumatology and Clinical Immunology
Urology

Clinical trials at this site (31)

Search interface

A study to evaluate Sotatercept in Participants with PAH WHO FC III or FC IV at High Risk of Mortality Ended

2023-509140-10-00 Pulmonary Arterial Hypertension (PAH) 5 2022-04-05
A Phase 2 Study to assess the efficacy and safety of 2 dosage regimens of oral fidrisertib (IPN60130) for the treatment of fibrodysplasia os… Ended

2024-511469-13-00 Fibrodysplasia Ossificans Progressiva 4 2021-10-19
A study of nivolumab and ipilimumab in untreated patients with stage 3 NSCLC that is unable or not planned to be removed by surgery Ended

2022-502886-71-00 Previously Untreated Locally Advanced Non-small Cell Lu 5 2019-11-20
A study to learn about the effects and safety of obeticholic acid in combination with bezafibrate in participants with primary biliary chola… Ended

2024-513762-18-00 Primary Biliary Cholangitis (PBC) 4 2019-09-20
A Phase 3, Multicenter, Randomized, Open-label Study to Compare the Efficacy and Safety of bb2121 Versus Standard Regimens in Subjects with … Ended

2023-509848-10-00 Multiple myeloma (MM) with at least 2 prior therapies i 5 2019-06-12
A study evaluating the efficacy and safety of ralinepag in treatment of patients with pulmonary arterial hypertension. Ended

2023-509304-16-00 Pulmonary arterial hypertension (PAH) 5 2019-05-16
A Phase 3 Study Comparing Daratumumab, VELCADE (bortezomib), Lenalidomide, and Dexamethasone (D-VRd) with VELCADE, Lenalidomide, and Dexamet… Ended

2023-507312-13-00 Multiple Myeloma 5 2018-11-15